According to Forbes, the companies involved in the supply chain for the Covid vaccine need to ramp up their security against cyber threats. 

Having developed Covid-19 vaccines in a fraction of the time it takes to create new treatments, pharmaceutical companies need to protect the priceless IP, supporting data and supply chains from cyberattacks.